PMID: 2121890Nov 1, 1990Paper

Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia

The Journal of Experimental Medicine
G E GrauP H Lambert

Abstract

The production of Interleukin 6 (IL-6) was studied during experimental cerebral malaria (ECM) induced by Plasmodium berghei ANKA (PbA) infection. IL-6 is present in the serum of mice with ECM, the highest concentrations being observed in mice with full-blown neurological syndrome. High IL-6 levels were also observed, however, in the absence of pathology in nonlethal malaria infection. These data suggest that IL-6 is produced in large amounts during malaria infection, but does not play a major role in the pathogenesis of ECM. A modulation of IL-6 production in ECM was achieved by in vivo treatment with other anticytokine antibodies: antibodies to interferon (IFN-gamma) or to tumor necrosis factor (TNF) abolished the rise of IL-6, while anti-IL-3 and anti-granulocyte/macrophage colony-stimulating factor antibodies only partially prevented this rise, suggesting that the two cytokines IFN-gamma and TNF are important intermediates in IL-6 production. Passive immunization against IL-6 did not prevent ECM, but significantly reduced serum IgG levels in malaria-infected mice. Thus, by its effects on B cells, IL-6 may be involved in hypergammaglobulinemia and immune-complex diseases, e.g., glomerulonephritis observed during malaria infec...Continue Reading

References

Jun 1, 1989·The Journal of Experimental Medicine·P BrouckaertW Fiers
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G E GrauP Vassalli
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J Van SnickR J Simpson
Feb 1, 1988·The Journal of Experimental Medicine·A MuraguchiT Kishimoto
Nov 5, 1984·Nature·M A Epstein

❮ Previous
Next ❯

Citations

Jan 1, 1991·Springer Seminars in Immunopathology·D Mazier, D Mattei
Jan 1, 1994·Biotherapy·W M Eling, P G Kremsner
Aug 2, 2007·Medical Microbiology and Immunology·Bernd LepeniesThomas Jacobs
Jul 1, 1992·Parasitology Today·T OlssonK Kristensson
Nov 19, 2002·International Journal for Parasitology·Andreas Heddini
Aug 1, 1997·Progress in Neurobiology·R A Gadient, U H Otten
Jul 1, 1994·Research in Immunology·G E Grau, C Behr
Mar 23, 2002·Microbes and Infection·J Brian de Souza, Eleanor M Riley
Aug 22, 2000·The Journal of Experimental Medicine·V PasquettoF V Chisari
May 1, 1995·Parasite Immunology·P H JakobsenJ H Playfair
Nov 1, 1996·International Journal of Dermatology·M T OchoaR Falabella
Nov 5, 2002·Clinical and Diagnostic Laboratory Immunology·Iñigo Angulo, Manuel Fresno
Nov 9, 2012·International Journal of Biological Sciences·María ErtaJuan Hidalgo
Dec 15, 2015·The Journal of Allergy and Clinical Immunology·Upasana KulkarniRudolf Armin Manz
Mar 14, 2007·International Journal for Parasitology·Ana Margarida VigárioSylviane Pied
Sep 24, 2004·Biochemical and Biophysical Research Communications·Akiko EnomotoMasahiko Hayashi
Mar 1, 1991·Parasite Immunology·S PiedD Mazier
Aug 1, 1992·European Journal of Immunology·H SuzukiT Kishimoto
Jan 1, 1992·Parasitology·K Marsh
Apr 13, 2017·Malaria Journal·Temitope W AdemolueGordon A Awandare
Jun 27, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiyue HeYaming Cao
Sep 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bernd LepeniesThomas Jacobs
Jul 1, 1994·Clinical Microbiology Reviews·T R Jones, S L Hoffman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.